In Canada, the federal court has fined Merck KGaA C$1 million ($689,900)for its role in a price-fixing cartel, that ran from 1991 to 1995, artificially inflating prices in the C$700 million-a-year bulk vitamin C market (Marketletters passim). In addition, the court has issued a 10-year prohibition order, during which any attempt by the company to engage in anticompetitive practices will carry significantly stronger penalties, according to the Ottawa Citizen newspaper.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze